Applications of 2D descriptors in drug design: a DRAGON tale

AM Helguera, RD Combes… - Current topics in …, 2008 - ingentaconnect.com
In order to minimize expensive drug failures, is essential to determine potential activity,
toxicity and ADME problems as early as possible. In view of the large libraries of compounds …

Biological activity and toxicity: A conceptual DFT approach

A Chakraborty, S Pan, PK Chattaraj - Applications of density functional …, 2013 - Springer
Quantitative structure–activity relationship (QSAR) models are generated for biological
activity and toxicity in terms of global and local reactivity descriptors within a conceptual …

Highly efficient Suzuki–Miyaura coupling of heterocyclic substrates through rational reaction design

CA Fleckenstein, H Plenio - Chemistry–A European Journal, 2008 - Wiley Online Library
Abstract A dicyclohexyl (2‐sulfo‐9‐(3‐(4‐sulfophenyl) propyl)‐9H‐fluoren‐9‐yl)
phosphonium salt was synthesized in 64% overall yield in three steps from simple …

MIND-BEST: Web Server for Drugs and Target Discovery; Design, Synthesis, and Assay of MAO-B Inhibitors and Theoretical− Experimental Study of G3PDH Protein …

H González-Díaz, F Prado-Prado… - Journal of proteome …, 2011 - ACS Publications
Many drugs with very different affinity to a large number of receptors are described. Thus, in
this work, we selected drug− target pairs (DTPs/nDTPs) of drugs with high affinity/nonaffinity …

Alignment-free prediction of a drug− target complex network based on parameters of drug connectivity and protein sequence of receptors

D Vina, E Uriarte, F Orallo… - Molecular …, 2009 - ACS Publications
There are many drugs described with very different affinity to a large number of receptors. In
this work, we selected drug− receptor pairs (DRPs) of affinity/nonaffinity drugs to …

Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola …

F Prado-Prado, X García-Mera, P Abeijón… - European journal of …, 2011 - Elsevier
There are many drugs described with very different affinity to a large number of receptors. In
this work, we selected Drug-Target pairs (DTPs/nDTPs) of drugs with high affinity/non-affinity …

Drug development to protozoan diseases

L Monzote, A Siddiq - The Open Medicinal Chemistry Journal, 2011 - pmc.ncbi.nlm.nih.gov
The diseases caused by protozoan parasite are responsible for considerable mortality and
morbidity, affecting more than 500 million of people in the world. The epidemiological control …

2D MI-DRAGON: a new predictor for protein–ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for …

F Prado-Prado, X García-Mera, M Escobar… - European journal of …, 2011 - Elsevier
There are many pairs of possible Drug–Proteins Interactions that may take place or not
(DPIs/nDPIs) between drugs with high affinity/non-affinity for different proteins. This fact …

First report on development of quantitative interspecies structure–carcinogenicity relationship models and exploring discriminatory features for rodent carcinogenicity …

S Kar, K Roy - Chemosphere, 2012 - Elsevier
Different regulatory agencies in food and drug administration and environmental protection
worldwide are employing quantitative structure–activity relationship (QSAR) models to fill the …

Natural/random protein classification models based on star network topological indices

CR Munteanu, H González-Díaz, F Borges… - Journal of theoretical …, 2008 - Elsevier
The development of the complex network graphs permits us to describe any real system
such as social, neural, computer or genetic networks by transforming real properties in …